Advertisement

Search Results for "Itraconazole Therapuetic Drug Monitoring"

07:10 EDT 21st May 2013 | BioPortfolio

Original Source: Level of Evidence for Therapeutic Drug Monitoring of Itraconazole.

Itraconazole is a triazole antifungal agent that is active against Aspergillus, histoplasmosis, and rare fungal infections. Itraconazole exhibit marked variability in drug concentration as a result of inconsistent absorption, metabolism, or interaction with concomitant medications. Preclinical and clinical data have exhibited a relationship between serum concentrations and treatment efficacy or toxicity, thus therapeutic drug monitoring (TDM) of itraconazole is largely used to optimise therapy. The analysis...

Matching Channels

Matching News

Mylan wins final FDA approval for Itraconazole capsules ANDA

Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application (ANDA) of Itraconazole capsules, 100mg, the generic version of Janssen Pharmaceutical's Sporanox capsules.

AAPS PharmSciTech: Formation of Itraconazole–Succinic Acid Cocrystals by Gas Antisolvent Cocrystallization

Type: Original PaperCocrystals of itraconazole, an antifungal drug with poor bioavailability, and succinic acid, a water-soluble dicarboxylic acid, were formed by gas antisolvent (GAS) cocrystallizati...

Mylan receives FDA approval for generic Sporanox ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) f...

Mylan Launches Generic Version of Sporanox® Capsules

PITTSBURGH, July 27, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Admin...

AAPS PharmSciTech: Miniaturized Transfer Models to Predict the Precipitation of Poorly Soluble Weak Bases upon Entry into the Small Intestine

Type: Brief CommunicationFor poorly soluble weak bases, the possibility of drug precipitation upon entry into the small intestine may affect the amount of drug available for uptake through the intesti...

AAPS PharmSciTech: Ditosylate Salt of Itraconazole and Dissolution Enhancement Using Cyclodextrins

Type: Original PaperSalt formation has been a promising approach for improving the solubility of poorly soluble acidic and basic drugs. The aim of the present study was to prepare the salt form of itr...

AAPS PharmSciTech: Influence of Formulation and Processing Variables on Properties of Itraconazole Nanoparticles Made by Advanced Evaporative Precipitation into Aqueous Solution

Type: Original PaperNanoparticles, of the poorly water-soluble drug, itraconazole (ITZ), were produced by the Advanced Evaporative Precipitation into Aqueous Solution process (Advanced EPAS). This pro...

MOH To Increase Monitoring Against Hospital Bribes

China’s Ministry of Health said it will further combat bribery of doctors and hospital staff by increasing monitoring, taking a hard line in concentrated drug procurements and delinking hospitals an...

Matching PubMed Articles

Level of Evidence for Therapeutic Drug Monitoring of Itraconazole.

Itraconazole is a triazole antifungal agent that is active against Aspergillus, histoplasmosis, and rare fungal infections. Itraconazole exhibit marked variability in drug concentration as a result of...

Itraconazole : an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.

Introduction: Fungal infections are a major source of global morbidity and mortality. Itraconazole is a triazole antifungal agent that is widely used for the prevention and treatment of fungal infecti...

Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers.

Objective. To investigate the pharmacokinetic interaction between ciprofloxacin and itraconazole in healthy male volunteers. Methods. Ten healthy male volunteers were assigned into a 2-sequence, 3-per...

Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.

To develop a novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability, various itraconazole-loaded solid dispersions were prepared with water, polyvinylpyrro...

Phase behavior of itraconazole-phenol mixtures and its pharmaceutical applications.

The aims of this study were to examine the phase behavior of itraconazole-phenol mixtures and assess the feasibility of topical formulations of itraconazole using eutectic mixture systems. Itraconazol...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement